# Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema

> **NCT07438509** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Jinnah Postgraduate Medical Centre** · enrollment: 270 (estimated)

## Conditions studied

- Atopic Dermatitis (AD)
- Atopic Eczema

## Interventions

- **DRUG:** Placebo Cream
- **DRUG:** Crisaborole 2% Cream

## Key facts

- **NCT ID:** NCT07438509
- **Lead sponsor:** Jinnah Postgraduate Medical Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07438509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07438509, "Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07438509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*